ALLOX closes $10.5M seed financing and appoints Morten Graugaard as Chair to scale allosteric drug discovery platform and build pipeline
quarter
View All ->
INTERIM REPORT FOR THE THIRD QUARTER OF 2026 (UNAUDITED)
GROUP CEO’S REVIEW Kert Keskpaik, CEO and Member of the Management Board of Arco Vara AS: “In the third quarter of 2026, Arco Vara AS continued its operations in the real estate development sector. The objectives for the quarter were to sell apartments and commercial premises held in inventory and to continue pre-sales in the Spordi and Iili developments. Design work and a review of the business plan are currently underway at Luther Quarter. The progress of each development project is summarised
SHELL PLC 3rd QUARTER 2026 AND NINE MONTHS UNAUDITED RESULTS
SHELL PLC 3rd QUARTER 2026 AND NINE MONTHS UNAUDITED RESULTS SUMMARY OF UNAUDITED RESULTS Quarters $ million Nine months Q3 2026 Q2 2026 Q3 2025 Reference* 2026 2025 12,057 10,821 5,322 Income attributable to Shell plc shareholders 28,573 13,703 10,814 9,836 5,432 Adjusted Earnings A. 27,565 15,273 22,736 20,710 14,773 Adjusted EBITDA A. 61,187 43,336 21,043 21,432 12,207 Cash flow from operating activities 48,538 33,425 (4,721) (3,908) (2,257) Cash flow from investing activities (11,765) (11,62
newsKalmar's interim report January–September 2026: Resilient third quarter with strong orders and robust cash generation
KALMAR CORPORATION, STOCK EXCHANGE RELEASE, 29 OCTOBER 2026 AT 9:00 AM (EET) Kalmar's interim report January–September 2026: Resilient third quarter with strong orders and robust cash generation Orders received grew by 22 percent to EUR 458 (375) million Sales was on the level of the comparison period, EUR 433 (436) million as growth in the Services compensated a modest decline in Equipment sales Eco portfolio share 1 of sales decreased to 43 (46) percent; however, eco portfolio order intake and
results
View All ->SHELL PLC 3rd QUARTER 2026 AND NINE MONTHS UNAUDITED RESULTS
SHELL PLC 3rd QUARTER 2026 AND NINE MONTHS UNAUDITED RESULTS SUMMARY OF UNAUDITED RESULTS Quarters $ million Nine months Q3 2026 Q2 2026 Q3 2025 Reference* 2026 2025 12,057 10,821 5,322 Income attributable to Shell plc shareholders 28,573 13,703 10,814 9,836 5,432 Adjusted Earnings A. 27,565 15,273 22,736 20,710 14,773 Adjusted EBITDA A. 61,187 43,336 21,043 21,432 12,207 Cash flow from operating activities 48,538 33,425 (4,721) (3,908) (2,257) Cash flow from investing activities (11,765) (11,62
Vistin Pharma ASA: Third quarter and YTD 2026 financial results
Vistin Pharma ASA: Third quarter and YTD 2026 financial results Oslo, Norway, 29 October 2026 Vistin Pharma ASA (VISTN) today announces its financial results for the third quarter and year to date 2026. Revenue in the third quarter amounted to MNOK 108.4, compared to MNOK 108.8 in Q3 2025. Sales volume increased by 13%, offset by a significantly stronger NOK against EUR in the quarter compared to 2025, impacting sales in local currency. Revenue for the first nine months of 2026 amounted to MNOK
newsInbank unaudited financial results for Q3 and 9 months of 2026
In Q3 2026, Inbank reached a record originated volume of €227 million, representing an 11% year-on-year increase. Consolidated net profit for the quarter grew by 26% year-on-year to €6.3 million. Net profit for the first nine months of 2026 reached €14.6 million, up 11% year-on-year. The return on equity was 14% in Q3, and 11.1% for the first 9 months of the year. Inbank’s total net income increased by 14% year-on-year to €25 million in the third quarter and by 9% to €68.8 million in the first n
Business Digest
newsSolid customer activity, broad-based growth and strong credit quality drove strong results for the first nine months of 2026. Net profit of DKK 18.3 bn. Outlook for the full year 2026 narrowed to a net profit in the range of DKK 24-25 bn
newsMolecular Partners Reports Q3 2026 Financial Results, Deepens Focus on Targeted Radiotherapy
newsStrong results despite lower generation
third
View All ->INTERIM REPORT FOR THE THIRD QUARTER OF 2026 (UNAUDITED)
GROUP CEO’S REVIEW Kert Keskpaik, CEO and Member of the Management Board of Arco Vara AS: “In the third quarter of 2026, Arco Vara AS continued its operations in the real estate development sector. The objectives for the quarter were to sell apartments and commercial premises held in inventory and to continue pre-sales in the Spordi and Iili developments. Design work and a review of the business plan are currently underway at Luther Quarter. The progress of each development project is summarised
Kalmar's interim report January–September 2026: Resilient third quarter with strong orders and robust cash generation
KALMAR CORPORATION, STOCK EXCHANGE RELEASE, 29 OCTOBER 2026 AT 9:00 AM (EET) Kalmar's interim report January–September 2026: Resilient third quarter with strong orders and robust cash generation Orders received grew by 22 percent to EUR 458 (375) million Sales was on the level of the comparison period, EUR 433 (436) million as growth in the Services compensated a modest decline in Equipment sales Eco portfolio share 1 of sales decreased to 43 (46) percent; however, eco portfolio order intake and
newsVistin Pharma ASA: Third quarter and YTD 2026 financial results
Vistin Pharma ASA: Third quarter and YTD 2026 financial results Oslo, Norway, 29 October 2026 Vistin Pharma ASA (VISTN) today announces its financial results for the third quarter and year to date 2026. Revenue in the third quarter amounted to MNOK 108.4, compared to MNOK 108.8 in Q3 2025. Sales volume increased by 13%, offset by a significantly stronger NOK against EUR in the quarter compared to 2025, impacting sales in local currency. Revenue for the first nine months of 2026 amounted to MNOK
announces
View All ->Fairfax Announces Successful Completion of Sale of Eurolife Life Insurance Operations to Eurobank
TORONTO, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces the successful completion of the previously announced sale of its 80% equity interest in the life insurance business operated by Eurolife FFH Insurance Group Holdings S.A. to Eurobank S.A. for cash consideration of approximately €813 million. Fairfax is a holding company which, through its subsidiaries, is primarily engaged in property and casualty insurance and reinsurance an
Fiverr Announces Third Quarter 2026 Results
Higher-value project growth: Projects at or above $1,000 represented 16% of completed projects' gross order amount on a trailing twelve-month basis. AI transformation investments: Advancing the platform by leveraging our Knowledge Graph to match talent based on delivered outcomes, scaling our new Mira AI headhunter to improve project scoping and conversion, and expanding into external LLM ecosystems. Capital allocation and liquidity: Generated $9.5 million in operating cash flow, $9.4 million in
newsMC Brazil Downstream Trading S.à r.l. Announces Termination of Its Tender Offer for Any and All of Its Outstanding 7.250% Senior Secured Notes Due 2031 and Related Consent Solicitation
THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION TO ANY PERSON LOCATED OR RESIDENT IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE SUCH ANNOUNCEMENT São Paulo, Brazil, Oct. 28, 2026 (GLOBE NEWSWIRE) -- MC Brazil Downstream Trading S.à r.l., a private limited liability company ( société à responsabilité limitée ) organized under the laws of the Grand Duchy of Luxembourg, having its registered office at L-1855 Luxembourg, 46A, Avenue John F. Kennedy, Grand Duchy of Luxembourg, and registered with
reports
View All ->
Molecular Partners Reports Q3 2026 Financial Results, Deepens Focus on Targeted Radiotherapy
Dosing ongoing in fully recruited dose level 2 of MP0712 Phase 1/2a study; initial safety data to be presented at North America Conference on Lung Cancer in December 2026, efficacy data expected in 2027 Emerging clinical data from lead Radio-DARPin candidate MP0712 enables strategic focus on radiopharmaceuticals Streamlining of organization, in line with corporate focus, to advance Radio-DARPin programs Cash position of CHF 57.5 million (USD ~69 million) as of September 30, 2026, expected to fun
Idorsia reports accelerating QUVIVIQ growth, advances key value drivers, and reaffirms full-year financial guidance
Ad hoc announcement pursuant to Art. 53 LR QUVIVIQ™ (daridorexant) sales reached CHF 142 million in the first nine months of 2026, with growth accelerating quarter-on-quarter. Idorsia reaffirms its full-year 2026 guidance and remains focused on further accelerating growth, maximizing the commercial opportunity of QUVIVIQ, and preparing the launch of TRYVIO/JERAYGO under the new leadership of CEO Roland Wandeler. Allschwil, Switzerland – October 29, 2026 Idorsia Ltd (SIX: IDIA) is a commercial-st
newsSTMicroelectronics Reports Q3 2026 Financial Results
PR No: C3419C STMicroelectronics Reports Q3 2026 Financial Results Q326 net revenues at $3.76 billion Gross margin at 37.3% Operating income at $367 million (non-U.S. GAAP 1 operating income at $429 million) Business outlook at mid-point: Q426 net revenues of $4.15 billion and gross margin of 39.0 % Geneva, October 29, 2026 – STMicroelectronics N.V. (“ST”) (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, reported U.S. GAAP financial re
Business Digest
newsTeck Reports Unaudited Third Quarter Results for 2026
newsMusic Market to Grow at a CAGR of 8.07% Through 2032 as Online Platforms Capture 88.49% Share, Reports Mordor Intelligence
newsCalifornia Water Service Group Reports Solid Third Quarter 2026 Results and Successful Execution of Business Strategy
Magazine Focus
The Business of Reinvention: How Companies Adapt to a Changing World
Change has become a permanent part of doing business. Markets shift faster, customer expectations evolve, technology redraws competitive boundaries and established operating models face constant pressure. This edition examines how companies can approach reinvention through smarter processes, digital capability, product thinking and organizational flexibility. It explores why adaptation is no longer a response to crisis, but an ongoing discipline for businesses seeking relevance, resilience and sustainable growth.
Reinvention does not always require abandoning what already works. Often, it begins with understanding what must change, what should remain and where new capabilities can create meaningful value. In this edition, we look at business transformation as a continuous process shaped by technology, customers and changing markets, with an emphasis on practical thinking rather than fashionable disruption.
The day in focus. Delivered to your inbox.
A concise daily briefing of key stories, insights and developments, selected by our editorial team.
By subscribing, you agree to our Privacy Policy. Unsubscribe at any time.